Rasph

ARXUM and the EIC Accelerator: Blockchain Lab Control, Then Insolvency

September 29, 2026841 words5 min

Pharmaceutical quality control labs must prove to regulators that their test data have not been altered, a requirement known as data integrity under Good Manufacturing Practice (GMP). ARXUM, a software company in Kaiserslautern, built B-LOCS, a system that records in real time every event on the files of laboratory software on a blockchain, so any change to raw data leaves a trace.

The European Innovation Council granted €1,538,250 towards a €2.27 million project that ran from July 2022 to June 2024. In January 2024, before the project ended, a provisional insolvency administrator was appointed for ARXUM, and in April 2024 the company entered liquidation, according to German register data compiled by North Data. Its former domain, arxum.com, now hosts an unrelated trading blog.

€1.54MEIC grant, 68% of a €2.27M project
19 of 24Project months before insolvency
0Named customers
i. L.In liquidation since April 2024

Company file

Legal entity
ARXUM GmbH i. L., HRB 32736, Amtsgericht Kaiserslautern
Registered name
Since June 2019, renamed from a shelf company
Business
Blockchain software for manufacturing companies
Product
B-LOCS, blockchain-based laboratory operations control
Affiliates in project
Entities in France and Bulgaria
Status
Provisional insolvency administrator January 2024 (Trier local court, 23 IN 11/24); liquidation April 2024
EIC project
B-LOCS, 1 Jul 2022 to 30 Jun 2024, closed
EIC funding
Grant first

What Happened to ARXUM

According to the register entries summarised by North Data, the local court of Trier appointed a provisional insolvency administrator for ARXUM by an order of 24 January 2024 (case 23 IN 11/24), published on 7 February 2024, and on 9 April 2024 the company entered liquidation; its name now carries the suffix "i. L." (in Liquidation). We found no public statement by the company. Its web domain has been taken over: the current arxum.com describes itself as "a strategy-research lab for forex, crypto, and derivatives markets" and has no link to the Kaiserslautern company.

The Technology: A Tamper-Proof Lab Log

According to the CORDIS fact sheet, B-LOCS "records in real time the events that occur on the files from the lab software" and detects alterations to raw data caused by errors or non-compliance with GMP. Records are stored in smart contracts on a blockchain, and deviations trigger configurable alerts.

"A first commercialisation is underway with selected pilot customers."

B-LOCS report, CORDIS

What the EIC Project Promised, and What CORDIS Shows

B-LOCS promised a "fully digital blockchain-based laboratory operations control system for real-time and audit-proof Good Manufacturing Practice conformity". The CORDIS report describes user interface work, a move of the software to the NestJS framework, a workflow configurator and blockchain infrastructure for testing, and says a first commercialisation was under way with pilot customers. It names no customers and gives no numbers, and it does not mention the insolvency.

  1. A working B-LOCS systemDeliveredSoftware developed, per CORDIS.
  2. Pilot customersPartial"Underway"; none named.
  3. Market launchMissedCompany liquidated.
  4. A company that continuesMissedInsolvent, January 2024.

What Has Happened Since the Award

The Money

The award was "grant first"; we found no EIC Fund investment. The German register shows ARXUM's share capital at €40,562 in 2021; its investors and accounts were not accessible for this article.

What cannot be checked

How much of the €1.54 million grant was paid out before the insolvency, whether the EU has a claim in the liquidation, who the pilot customers were and what happened to the software are not public.

Why Europe Should Care

Drug makers must be able to prove their lab data are genuine, and B-LOCS aimed at that need. This case also raises a question about EIC reporting: the project's public results speak of commercialisation under way and do not mention that the company became insolvent before the project ended.

What the project promised

A fully digital, audit-proof blockchain system for GMP-compliant laboratory operations.

What the record shows

Software and pilot talks, then insolvency before the project ended, liquidation and a lost domain.

The Verdict

Insolvent mid-project

B-LOCS built its software, but ARXUM ran out of money before the project was finished. The EU's public record of the project does not mention the insolvency, and there is no sign the product survives.

ARXUM is in liquidation and could not be asked for comment. This article is based on EU project data and German register information, linked throughout.

Start with the EIC Accelerator

Professional proposal writing and expert review for Step 1 and Step 2.

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges is a new pilot program offering €300,000 (Stage 1) and up to €2.5 million (Stage 2) for breakthrough deep-tech solutions through ARPA-style staged funding with demand-side integration. The program targets single entities or small consortia (2-3 partners) including SMEs, start-ups, and research organizations. Focus areas include Physical AI for autonomous robotics and New Approach Methodologies (NAMs) for animal-free biomedical testing, requiring TRL 4 entry with end-user commitment.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
EIC AcceleratorBeneficiary Deep Dive#ARXUM#B-LOCS#blockchain#GMP#pharmaceutical manufacturing#data integrity#insolvency#Germany
Loading